You are here


Protesting activists have demanded that the price for the blockbuster tuberculosis drug bedaquiline be slashed, at the opening of 49th Union World Conference on Lung Health, in the Netherlands.
A book telling the powerful stories of 13 child tuberculosis (TB) survivors and their families was launched at the 49th Union World Conference, to raise awareness of childhood TB and stigma.
For people like me who have devoted their entire medical careers to the fight against tuberculosis, there are finally some reasons to be optimistic about the fight against this scourge. This week, tuberculosis experts from 125 countries are gathering in Amsterdam, surrounded by a buzz of optimism that political leaders will finally come through on their commitments to fight the world’s most deadly infectious disease.
Today at the 2018 Union Conference, the Stop TB Partnership is issuing several documents to help advocates hold their leaders to account over the next few years for delivery of the targets contained in the Political Declaration from the recent historic UN High-Level Meeting (HLM) on TB.
The Minister of Health, Dr Aaron Motsoaledi, will this evening receive two prestigious Kochon Prizes. He will receive the first prize in his individual capacity for his role and political leadership in fight against Tuberculosis globally. The second prize, which he will share with the Right Honourable Nick Hebert, Member of Parliament in the United Kingdom, will be in their capacity as co-chairs of the Global TB Caucus of members of parliament from all over the world. The Kochon Prize is awarded annually to individuals and/or organizations that have made a significant contribution to combating TB either in their countries or globally.
A new treatment for a drug-resistant strain of tuberculosis can cure more than 90 per cent of sufferers, according to a trial hailed Monday as a “game changer” in the fight against the global killer.
USAID announced September 26 a new approach to fight tuberculosis: the Global Accelerator to End TB, a business model to treat 40 million people by 2022 through performance-based investments. One of USAID’s initial efforts on this front is a program to improve the collection, analysis, use, and global harmonization of TB data.
World leaders in the General Assembly today reaffirmed their commitment to end the global tuberculosis epidemic by 2030, unanimously adopting a political declaration committing them to accelerate national and collective actions, investments and innovations in fighting the preventable disease.
World leaders meeting today at the United Nations (UN) General Assembly have committed to ensure that 40 million people with tuberculosis (TB) receive the care they need by end 2022. They also agreed to provide 30 million people with preventive treatment to protect them from developing TB.
The World Health Organization says governments have agreed to contribute $13 billion a year by 2022 to prevent and treat tuberculosis, a communicable disease that claimed at least 1.3 million lives last year.